Suppr超能文献

应用改良的液滴数字 PCR 技术检测细菌 DNA 对自发性细菌性腹膜炎的临床评估。

Clinical evaluation of bacterial DNA using an improved droplet digital PCR for spontaneous bacterial peritonitis diagnosis.

机构信息

Beijing YouAn Hospital, Capital Medical University, Beijing, China.

Beijing Institute of Hepatology, Beijing YouAn Hospital, Capital Medical University, Beijing, China.

出版信息

Front Cell Infect Microbiol. 2022 Aug 18;12:876495. doi: 10.3389/fcimb.2022.876495. eCollection 2022.

Abstract

OBJECTIVE

Bacterial DNA (bactDNA) detection can be used to quickly identify pathogenic bacteria and has been studied on ascitic fluid. We aimed to retrospectively analyze the diagnostic value and applicational prospect of the bactDNA load in spontaneous bacterial peritonitis (SBP).

METHOD

We extracted viable bactDNA from ascitic samples of 250 patients with decompensated cirrhosis collected from October 2019 to April 2021 and detected the bactDNA by droplet digital polymerase chain reaction (ddPCR). We used ascitic samples of a baseline cohort of 191 patients to establish diagnostic thresholds for SBP and analyze the patients' diagnostic performance based on ascites polymorphonuclear (PMN) and clinical manifestation. We performed bactDNA quantification analysis on 13 patients with a PMN less than 250 cells/mm but with clinical symptoms. The dynamic changes of the bactDNA load from eight patients (before, during, and after SBP) were analyzed.

RESULTS

After the removal of free DNA, the bactDNA detected by ddPCR was generally decreased (1.75 vs. 1.5 log copies/µl, P < 0.001). Compared with the traditional culture and PMN count in the SBP diagnosis, the bactDNA showed that the ddPCR sensitivity was 80.5%, specificity was 95.3%, positive predictive value was 82.5%, and negative predictive value was 94.7%, based on clinical composite criteria. In patients with a PMN less than 250 cells/mm, the bactDNA load of 13 patients with symptoms was significantly higher than those without symptoms (2.7 vs. 1.7 log copies/µl, P < 0.001). The bactDNA in eight patients had SBP that decreased by 1.6 log copies/µl after 48 h of antibiotic treatment and by 1.0 log copies/µl after 3 days of continued treatment.

CONCLUSION

BactDNA detection can be used to further enhance the diagnostic efficiency of SBP. Therefore, the application of ddPCR assay not only can be used to discriminate and quantify bacteria but also can be used in the clinical assessment for antibiotics treatment.

摘要

目的

细菌 DNA(bactDNA)检测可用于快速鉴定致病菌,并已在腹水方面进行了研究。我们旨在回顾性分析自发性细菌性腹膜炎(SBP)中细菌载量的诊断价值和应用前景。

方法

我们从 2019 年 10 月至 2021 年 4 月收集的 250 例失代偿性肝硬化患者的腹水样本中提取有活力的 bactDNA,并通过液滴数字聚合酶链反应(ddPCR)进行检测。我们使用 191 例基线队列患者的腹水样本建立 SBP 的诊断阈值,并根据腹水中性粒细胞(PMN)和临床表现分析患者的诊断性能。对 13 例 PMN 小于 250 个细胞/mm 但有临床症状的患者进行 bactDNA 定量分析。分析了 8 例患者(SBP 前后)bactDNA 负荷的动态变化。

结果

ddPCR 检测到的 bactDNA 在去除游离 DNA 后普遍降低(1.75 对数拷贝/µl 比 1.5 对数拷贝/µl,P<0.001)。与传统培养和 SBP 诊断中的 PMN 计数相比,ddPCR 的细菌灵敏度为 80.5%,特异性为 95.3%,阳性预测值为 82.5%,阴性预测值为 94.7%,基于临床综合标准。在 PMN 小于 250 个细胞/mm 的患者中,有症状的 13 例患者的 bactDNA 负荷明显高于无症状患者(2.7 对数拷贝/µl 比 1.7 对数拷贝/µl,P<0.001)。在 8 例患者中,抗生素治疗 48 小时后细菌载量降低 1.6 对数拷贝/µl,继续治疗 3 天后降低 1.0 对数拷贝/µl。

结论

bactDNA 检测可用于进一步提高 SBP 的诊断效率。因此,ddPCR 检测不仅可用于区分和定量细菌,还可用于临床评估抗生素治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dce/9433567/1dacf88813ec/fcimb-12-876495-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验